Dermatophyte abscesses caused by Trichophyton rubrum in a patient without pre-existing superficial dermatophytosis: a case report
- 946 Downloads
Trichophyton usually causes a superficial skin infection, affecting the outermost layer of the epidermis, the stratum corneum. In immunocompromised patients, deeper invasion into the dermis and even severe systemic infection with distant organ involvement can occur. Most cases of deeper dermal dermatophytosis described in the literature so far involved pre-existing superficial dermatophytosis.
We report a 68-year-old woman presented to our clinic with a 3-month history of palpable nodules on the right ankle without pre-existing superficial dermatophytosis. Magnetic resonance imaging showed multiple, well-demarcated, cystic lesions around the lateral malleolus, located in the subcutaneous or dermal layers. The sizes varied from 0.5 cm to 4 cm in diameter. The patient underwent complete excision of the lesions. Fungal culture yielded Trichophyton rubrum on Sabouraud dextrose agar. Histopathology showed organizing abscesses with degenerated fungal hyphae. After the 12-week oral itraconazole therapy, the lesions were completely resolved.
Dermatophytes should be considered as a possible cause of deep soft tissue abscesses in immunocompromised patients, even though there is no superficial dermatophytosis lesion.
KeywordsTrichophyton Dermatophyte Abscess Soft tissue
Trichophyton is a dermatophytic fungus, which is often responsible for nail, hair follicle, and superficial skin infections [1, 2]. In rare cases, it can cause a dermatophyte abscess in deeper skin layers or even disseminate to internal organs, including the lymph nodes, brain, liver, muscle, and bone. This can happen particularly in human immunodeficiency virus-infected or other immunocompromised patients [3, 4, 5]. The deep lesions are usually accompanied by superficial dermatophytosis.
Here, we describe a case of recurrent, multiple, dermatophyte abscesses caused by Trichophyton rubrum in an immunocompromised patient without pre-existing superficial dermatophytosis.
A 68-year-old woman presented with a 3-month history of recurrent, multiple, subcutaneous nodules on the right ankle. Seven months previously, she had undergone complete excision of similar lesions at nearly the same sites at another hospital. Pathological examination had shown multiple abscesses with many fungal hyphae, but antifungal therapy was not prescribed. For the previous 7 years, she had been on medication for type 2 diabetes mellitus and hypertension, and for the previous 5 years, she had additionally been taking a daily dose of 10 mg prednisolone to treat psoriasis.
The patient was diagnosed with recurrent dermatophyte abscesses caused by Trichophyton rubrum, and oral itraconazole 200 mg once daily was started. Oral prednisolone slowly tapered and stopped 3 weeks after operation. She was discharged without any postoperative complications and prescribed continued oral itraconazole. After the 12-week oral itraconazole treatment course, the surgical wound remained clean and there was no evidence of the development of new lesions. A follow-up magnetic resonance imaging of the same site also showed no remnant abscess or any sign of recurrence. The patient did not show any recurrence at the 2.5 years follow-up.
Dermatophytes are fungi that commonly cause skin disease in humans and animals worldwide. Three types of dermatophytes, Trichophyton, Microsporum, and Epidermophyton, account for the majority of infections, which share similar pathognomonic characteristics; these are commonly referred to as ringworm . Trichophyton rubrum is the most prevalent causative agent of human dermatophytosis, affecting nearly 90 % of patients with a dermatophyte infection in Korea [6, 7]. The infection can involve any area of the skin, but the most frequently affected sites are the feet (tinea pedis), groin (tinea cruris), scalp (tinea capitis), and nails (tinea unguium) .
These dermatophyte fungi typically attack the skin, hair, and nails because they require keratin for growth. In immunocompetent hosts, they cannot penetrate deeper than the stratum granulosum and their colonies are not usually observed in the layer over the epidermis. However, deeper dermis and subcutaneous dermatophyte infections can occur in patients with compromised immune systems, caused by solid organ transplantation, hematological malignancy, immunosuppressive therapy, or congenital immune deficiency [8, 9]. In these cases, the fungi can enter the bloodstream and disseminate to distant major organs, including the lymph nodes, liver, brain, and bone. This often causes systemic infections, which can be fatal [3, 10, 11].
A recent article provided a descriptive review of 46 cases of dermatophyte abscess . Similar to our case, 38 patients (83 %) were immunocompromised, including those with solid organ transplantation, hematological malignancy, collagen disease, nephrotic syndrome, bullous pemphigoid, and diabetes mellitus. The majority of patients (83 %) presented with multiple nodules, and the lower extremities were most frequently affected (54 %). Most patients had pre-existing superficial dermatophytosis. More specifically, 12 of 14 cases (86 %) reported after 1999 involved superficial dermatophytosis (information was not available in the other 2 cases). In our case, however, there was neither a concomitant lesion nor a previous history of superficial dermatophytosis at any site of the body. Therefore, it was more difficult to make a definitive diagnosis.
The standard treatment for a dermatophyte abscess is not well established. In a recent article, various therapies were reported to have been used . Most patients received systemic antifungal therapy, including amphotericin B, griseofulvin, fluconazole, itraconazole, micafungin, and terbinafine. Two patients were successfully treated with combined antifungal therapy and surgical excision. Colwell et al. reported a case of a dermatophyte abscess on the scalp caused by Microsporum canis, which was resolved after surgical excision without any antifungal therapy . In contrast, the lesions in our case recurred several months after complete excision. Because the pathogenesis of deep dermatophytosis is poorly understood, we cannot fully explain the recurrence. However, there are a few possible explanations: (1) a difference in the causative fungi (M. canis vs. Trichophyton species); (2) a difference in the portal of entry of the fungi based on the presence of superficial dermatophytosis (data not available vs. no superficial dermatophytosis); and (3) a difference in the mode of spread inferred from the number of lesions (1 vs. multiple). In addition, the appropriate duration of antifungal therapy for a dermatophyte abscess is not yet established. Treatment should be according the severity of infection. Our patient was treated with itraconazole 200 mg daily for 12 weeks, the schedule commonly used in the treatment of tinea unguium.
We report a rare case of dermatophyte abscesses caused by Trichophyton rubrum in an immunocompromised patient without pre-existing superficial dermatophytosis. A lack of experience with dermatophytosis could make clinicians underestimate the significance of positive dermatophyte fungal cultures obtained from deep soft tissue. Even without any superficial dermatophytosis lesion, fungi should be considered as a possible cause of deep soft tissue abscesses in immunocompromised patients, and a culture for fungi as well as bacteria should be performed in these patients.
There was no external funding source for this case report.
Availability of data and materials
Kim SH performed the clinical assessments and drafted the manuscript and figures. Jo IH performed the clinical assessments, the interpretations of data, and assisted in drafting the manuscript. Kang J carried out the histopathological diagnosis and obtained their images. Joo SY performed the surgical support in the patient clinical care. Choi JH drafted the manuscript and reviewed it. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent it available for review by the Series Editor of this journal.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.